EMA recalls heart medicine valsartan made by Chinese firm over potential cancer-causing residue 글 내용 전체보기
Eisai Announces Acceptance of BAN2401 Phase II Results for Oral Presentation at the 2018 Alzheimer’s Association International Conference (AAIC) 글 내용 전체보기
Canntab announces collaboration and profit sharing agreement with FSD Pharma to produce and market oral dose delivery platforms 글 내용 전체보기
BioArctic Announces Acceptance of BAN2401 Phase 2b Results for Oral Presentation at the AAIC 2018 글 내용 전체보기
Beleaguered Regulus Therapeutics Slashes 60 Percent of Workforce in New Corporate Restructuring 글 내용 전체보기
Arizona Science Center Receives $1 Million Grant from APS Foundation to Expand STEM Education in Rural Arizona Schools 글 내용 전체보기
AHF Condemns PhRMA’s ‘Undue Influence’ on Congress; ‘Politico’ Ads Expose Industry’s Efforts to Kneecap 340B Drug Program 글 내용 전체보기
Advisory – Several drugs containing valsartan being recalled due to contamination with a potential carcinogen 글 내용 전체보기
